Know Your Tumor initiative matches treatments with patients
New recommendations for second-line therapy
Does tumor location matter?
Response to larotrectinib “almost miraculous”
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
May increase some pancreatic cancer survival rates
Can preoperative chemotherapy improve overall survival?
Researchers consider alternatives for high-risk patients
Program to study DNA, RNA alterations, test targeted therapies
Study confirms feasibility, benefits of large-scale cancer genomics in the clinic
Wide-scale analysis finds targets; drug trials underway